申请人:Merrell Dow Pharmaceuticals Inc.
公开号:US04443462A1
公开(公告)日:1984-04-17
Novel compounds of the formula ##STR1## wherein n is an integer of from 2 to 5, R is hydrogen, alkyl, alkoxy, halogen or trifluoromethyl, R.sub.1 is hydrogen, alkyl, alkoxy or halogen, and Z is carbonyl or hydroxymethylene and their pharmaceutically acceptable acid addition salts are useful as antipsychotic agents having a low potential for extrapyramidal side effects. The novel compounds are prepared from novel intermediates of formula ##STR2## or their salts wherein R has the meanings defined above and R.sub.2 is hydrogen, lower alkyl or phenyl(lower alkyl).
公式为##STR1##的新化合物,在此式中n为2至5的整数,R为氢、烷基、烷氧基、卤素或三氟甲基,R.sub.1为氢、烷基、烷氧基或卤素,Z为羰基或羟甲基,以及它们的药学上可接受的酸盐,可用作具有低额外锥体副作用潜力的抗精神病药物。这些新化合物是从公式##STR2##或其盐的新中间体制备而成,其中R具有上述定义的含义,R.sub.2为氢、低烷基或苯基(低烷基)。